Search results
Novavax executive Dubovsky sells shares worth over $657k By Investing.com
Investing.com· 5 days agoOn May 14, Dubovsky sold a total of 47,312 shares of Novavax common stock, with the sales amounting...
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 17 hours agoPrice Performance Review of NVAX On Friday, Novavax, Inc. [NASDAQ:NVAX] saw its stock fall -9.65% to $13.01. Over the last five days, the stock ...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 20 hours agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 1 day agoNovavax reported positive developments in its latest quarterly update that doubled its share price...
Novavax Stock Just Tripled. Is It Too Late to Buy?
The Motley Fool via AOL· 6 days agoThe biotech soared 190% in two trading sessions after announcing a $1.2 billion vaccine-licensing deal with French pharmaceutical giant Sanofi. The...
Is Novavax, Inc. (NASDAQ: NVAX) Stock On Course For Another Boom Or Bust? – Marketing Sentinel
Marketing Sentinel· 5 days agoDuring the recent session, Novavax, Inc. (NASDAQ:NVAX)’s traded shares were 7.57 million, with the beta value of the company hitting 1.91. At the last check today, the < ...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 5 hours agoSales of Pfizer Moderna, and Novavax shots fell far below expectations last year, setting off steep ...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters· 12 hours agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 2 days ago*Stock Advisor returns as of May 13, 2024 David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 7 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
